Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Laura Lorenzetti
Stay informed with Laura Lorenzetti’s coverage and analysis for Fortune.
Page 40 of 73
Tech
Imprivata, bulking up in health-care data security, buys biometrics maker HT Systems
By
Laura Lorenzetti
Features
Wal-Mart in China, and Microsoft techies — 5 things to know today
By
Laura Lorenzetti
Features
Baltimore riots, Google, and Twitter earnings — 5 things to know today
By
Laura Lorenzetti
Features
6 places where genetically engineered crops are banned
By
Laura Lorenzetti
Retail
Chipotle nixes genetically modified ingredients from its menu
By
Laura Lorenzetti
Features
Apple reports, and Deutche Bank cuts — 5 things to know today
By
Laura Lorenzetti
Features
Betting big on health
By
Laura Lorenzetti
Tech
Intel-Edico partnership aims to break a medical logjam
By
Laura Lorenzetti
Features
We need more antibiotics
By
Laura Lorenzetti
Features
Facebook reports, and Tesco’s historic loss — 5 things to know today
By
Laura Lorenzetti
Retail
The bird flu outbreak is bad for food companies, but it’s not a public health crisis — here’s why
By
Laura Lorenzetti
Finance
Teva offers to buy rival Mylan for $40 billion to create generics giant
By
Laura Lorenzetti
Retail
Blue Bell Creameries pulls all its products over listeria risk
By
Laura Lorenzetti
Features
EU goes after Gazprom, and Teva eyes Mylan — 5 things to know today
By
Laura Lorenzetti
Features
China adds more stimulus, and IBM reports — 5 things to know today
By
Laura Lorenzetti